首页> 外文期刊>Journal of Clinical Oncology >High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma.
【24h】

High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma.

机译:巨噬细胞集落刺激因子在肿瘤周围肝组织中的高表达与根治性肝细胞癌切除术后存活率低有关。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

PURPOSE: To investigate prognostic values of the intratumoral and peritumoral expression of macrophage colony-stimulating factors (M-CSF) in hepatocellular carcinoma (HCC) patients after curative resection. PATIENTS AND METHODS: Expression of M-CSF and density of macrophages (M Phi) were assessed by immunohistochemistry in tissue microarrays containing paired tumor and peritumoral liver tissue from 105 patients who had undergone hepatectomy for histologically proven HCC. Prognostic value of these and other clinicopathologic factors was evaluated. RESULTS: Neither intratumoral M-CSF nor M Phi density was associated with overall survival (OS) or disease-free survival (DFS). High peritumoral M-CSF and M Phi density, which correlated with large tumor size, presence of intrahepatic metastasis, and high TNM stage, were independent prognostic factors for both OS (P = .001 and P < .001, respectively) and DFS (P = .001 and P = .003, respectively) and affected incidence of early recurrence. In a small HCC subset, peritumoral M-CSF was also correlated with both OS and DFS (P = .038 and P = .001, respectively). The combination of peritumoral M-CSF and M Phi had a better power to predict the patients' death and disease recurrence (P < .001 for both). CONCLUSION: High peritumoral M-CSF and M Phi were associated with HCC progression, disease recurrence, and poor survival after hepatectomy, highlighting the importance of peritumoral tissue in the recurrence and metastasis of HCC. M-CSF and M Phi may be targets of postoperative adjuvant therapy.
机译:目的:探讨巨噬细胞集落刺激因子(M-CSF)在肝癌(HCC)患者术后根治术中的肿瘤内和肿瘤周围表达的预后价值。病人和方法:通过免疫组织化学方法,对来自105例经组织学证实为肝癌切除术的肝癌患者的肿瘤和肿瘤周围肝组织配对的组织微阵列,通过免疫组织化学方法评估了M-CSF的表达和巨噬细胞的密度。评估这些和其他临床病理因素的预后价值。结果:瘤内M-CSF和M Phi密度均与总生存期(OS)或无病生存期(DFS)相关。肿瘤周围的高M-CSF和M Phi密度与大肿瘤尺寸,肝内转移的存在以及高TNM分期相关,分别是OS(P = .001和P <.001)和DFS的独立预后因素。分别为P = .001和P = .003)并影响早期复发的发生率。在小的HCC子集中,肿瘤周围M-CSF也与OS和DFS相关(分别为P = .038和P = .001)。肿瘤周围M-CSF和M Phi的结合可以更好地预测患者的死亡和疾病复发(两者均P <.001)。结论:肿瘤周围M-CSF和M Phi高与肝切除术后肝癌的进展,疾病复发和生存期差有关,这突出了肿瘤周围组织在肝癌的复发和转移中的重要性。 M-CSF和M Phi可能是术后辅助治疗的目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号